Original price was: $119.99.$99.98Current price is: $99.98.
Research Studies:
Blend Specification:
FREE Shipping on
orders over $200
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
BPC-157 + TB-500 (10mg Blend) is a research-use-only peptide blend supplied for controlled laboratory workflows, multi-compound documentation review, and analytical characterization. This blend is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.
BPC-157 + TB-500 (10mg Blend) is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
| CAS No. | 137525-51-0 |
|---|---|
| Purity | ≥99% |
| Molecular Formula | C62H98N16O22 |
| Molecular Weight | 1419.535 g/mol |
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Synthesis | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for 24 months at -20°C in lyophilized form. After reconstitution, store at 4°C for up to 2 weeks or -20°C for up to 6 months. |
| Appearance | White crystalline powder |
| Shipping Conditions | Shipped at room temperature. Upon receipt, store at -20°C |
| Regulatory/Compliance | Complies with research use only standards. Not for drug, household, or other uses. |
| Safety Information | Refer to MSDS; handle according to established laboratory safety procedures |
Consider these supplementary peptides for a comprehensive research approach.
Researchers searching for buy BPC-157+TB-500 Blend online should evaluate BPC-157+TB-500 Blend as a research-use-only laboratory material, not a consumer product. For laboratory buyers, the key considerations are blend composition, compound identity, purity documentation, batch-specific COAs, lot traceability, product labeling, and storage information. This guide explains how to evaluate BPC-157+TB-500 Blend for controlled research procurement through Pure Lab Peptides while keeping the review focused on documentation, analytical testing, and supplier evaluation.
Researchers can buy BPC-157+TB-500 Blend online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption.
The phrase buy BPC-157+TB-500 Blend online is addressed here as laboratory research procurement intent, not personal-use intent. In this context, the searcher is a qualified researcher, laboratory buyer, research institution, or technical procurement team evaluating whether a research-use-only peptide blend is properly labeled, documented, and traceable.
Research procurement is not the same as consumer shopping. A compliant review should focus on whether the supplier identifies the material as research use only, whether the BPC-157+TB-500 Blend COA is batch-specific, whether purity documentation is supported by an analytical method, whether identity testing is described, and whether lot numbers align across the vial label, product page, and certificate of analysis. RUO labeling is especially important because FDA guidance on research-use-only in vitro diagnostic products illustrates how RUO language separates research-stage materials from diagnostic-use positioning, even though that guidance is not peptide-specific [1].
For a blend, the documentation review must also address component-level identity. BPC-157 and TB-500 should not be evaluated as a generic “peptide mix.” Researchers should review the named components, product form, labeled fill size, storage information, and available batch documentation before procurement. Blend composition should be evaluated through documentation and identity review, not expected outcomes or use protocols.
BPC-157+TB-500 Blend is best described as a research-use-only peptide blend that combines a BPC-157-labeled component with a TB-500-labeled component. Product shorthand should not replace analytical documentation. The BPC-157 component is identified in PubChem as BPC-157, CID 9941957, with a listed molecular formula of C62H98N16O22 [2]. FDA’s GSRS record for BPC-157 lists the name BPC-157 and related substance information, providing another identity-oriented database reference for the compound name [3].
The TB-500 component is commonly treated as a thymosin beta-4-related synthetic peptide in research-material contexts, but procurement teams should confirm the precise identity from the product page and batch-specific COA rather than relying on shorthand alone. PubChem lists TB-500 under UNII QHK6Z47GTG with a molecular formula of C38H68N10O14 [4], while a separate PubChem record identifies TB500 acetate as C40H72N10O16 [5]. FDA’s GSRS also maintains a TB-500 substance page [6].
Thymosin beta-4 is a distinct endogenous peptide reference point, not automatically the same thing as every TB-500-labeled research material. PubChem lists thymosin beta-4 separately [7], and UniProt identifies the human thymosin beta-4 entry P62328 under the TMSB4X gene [8]. Early chemical characterization literature described thymosin beta-4 as a low-molecular-weight peptide with an established amino acid sequence [9]. Structural literature has examined thymosin beta-4 in actin-sequestration models, which is useful as scientific context but not as BPC-157+TB-500 Blend product-use guidance [10].
For procurement purposes, the most relevant identity question is not whether a general database record exists. The relevant question is whether the delivered BPC-157+TB-500 Blend research material is supported by batch-specific documentation that links the product name, lot number, identity method, purity result, and storage instructions.
Researchers search this phrase when they need to compare RUO product availability, documentation practices, and supplier transparency. A laboratory buyer may want to know whether a supplier provides a batch-specific COA, whether the certificate names both blend components, whether the labeled amount matches the product page, and whether the product form is documented as lyophilized powder.
Teams that intend to buy BPC-157+TB-500 Blend for laboratory research should focus on evidence that can be recorded in procurement files. Useful evidence includes a product page, product label, batch number, BPC-157+TB-500 Blend purity documentation, BPC-157+TB-500 Blend identity testing, storage notes, and BPC-157+TB-500 Blend supplier documentation. The phrase buy BPC-157+TB-500 Blend online for laboratory research should therefore be read as a documentation-review workflow, not as a prompt for personal-use instructions.
Peptide blends require extra caution because a single purity percentage may not describe each component in the same way. Analytical guidelines such as ICH Q2(R2) discuss validation elements for procedures used to measure identity, purity, impurities, and other attributes [11]. Analytical procedure development guidance also emphasizes science-based approaches to methods used for quality assessment [12]. Those concepts support a documentation-first procurement review for RUO materials.
Researchers who buy BPC-157+TB-500 Blend online for laboratory research should review the same quality signals they would document for other RUO peptide materials: labeling, identity, purity, lot traceability, storage information, and supplier language. For blends, the review should also ask whether the documentation clearly identifies the material as a combined product rather than a single compound.
| Evaluation Area | What Researchers Should Review | Why It Matters for RUO Procurement |
| RUO labeling | Confirm the product is clearly labeled for research use only | Helps separate research procurement from human-use positioning |
| COA availability | Review the batch-specific certificate of analysis | Supports lot-level documentation and quality review |
| Purity data | Look for analytical support for the stated purity | Helps evaluate material consistency |
| Identity testing | Review HPLC, LC-MS, mass spectrometry, or related identity data | Helps confirm the material matches the listed blend |
| Lot traceability | Match lot numbers across product and documentation | Supports research recordkeeping |
| Product form | Confirm whether the material is supplied as lyophilized powder or another documented form | Supports laboratory planning |
| Storage information | Review storage and handling documentation | Helps maintain material integrity in laboratory settings |
| Supplier language | Confirm the supplier avoids dosing, therapeutic, diagnostic, or personal-use claims | Supports research-use-only positioning |
A certificate of analysis should be read as a batch-level record, not as a marketing sentence. NIST defines a Certificate of Analysis in the reference-material context as a certificate issued for a standard reference material certified for one or more specific chemical properties [13]. NIST also distinguishes reference materials, certified reference materials, and related documentation types, which is useful context for laboratory buyers reviewing supplier paperwork [14]. ISO 17034 describes competence and consistent operation requirements for reference material producers, reinforcing the broader point that documented identity, value assignment, and traceability matter in analytical-material workflows [15].
For BPC-157+TB-500 Blend, researchers should review the compound name, blend name, lot number, test date, purity percentage, testing method, identity confirmation, molecular weight information where provided, sequence information where provided, chromatogram or mass data when supplied, product form, and storage documentation. A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together.
HPLC is widely used for peptide separation, analysis, and purification, including reversed-phase approaches for peptide workflows [16]. Mass spectrometry is also used to characterize synthetic peptide identity and impurity patterns [17]. Reference-standard literature describes the use of RP-HPLC to evaluate lot homogeneity, stability, identity, content, and purity for synthetic peptide standards [18]. LC-HRMS literature further illustrates how high-resolution mass spectrometry can support qualitative and quantitative characterization of peptide-related impurities [19].
For peptide blends, procurement files should also preserve supplier correspondence and product page records. If a later audit or internal review asks why a BPC-157+TB-500 Blend research-use-only material was accepted into inventory, the laboratory should be able to point to the batch-specific COA, product labeling, lot match, and identity documentation rather than a generic catalog description.
Published literature mentions BPC-157, TB-500, thymosin beta-4, and synthetic peptides in several different ways. Some sources are database records that identify molecular formulas, names, synonyms, or substance identifiers [2] [4]. Some literature is biochemical or structural, such as thymosin beta-4 sequence and actin-model research [9] [10]. Other literature is analytical, describing HPLC, LC-MS, LC-HRMS, reference standards, impurity characterization, and peptide quality assessment [16] [17] [18].
This evidence landscape should be interpreted cautiously. Database records can support identity review, but they do not prove that a delivered lot matches the label. Analytical-method literature can explain why orthogonal methods are useful, but it does not verify a specific supplier lot. Published pathway literature can supply background for controlled laboratory research, but it should not be converted into claims about a product.
Research literature related to cellular pathways should not be converted into product-use claims for RUO materials. Published clinical literature should not be interpreted as use guidance for RUO materials. For BPC-157+TB-500 Blend, the appropriate procurement conclusion is narrow: researchers should review component identity, blend documentation, COA availability, purity method, lot traceability, and storage information before selecting an RUO supplier.
| Research Area | What Literature Examines | Evidence Type | RUO Interpretation |
| Compound identity | Molecular structure, sequence, formula, or classification for BPC-157, TB-500, and thymosin beta-4-related records | Database / analytical | Supports identification, not product-use claims |
| Pathway or category context | Peptide identity, thymosin beta-4-related biochemical models, and cellular pathway research context | Review / in vitro / preclinical | Useful for research context, not therapeutic claims |
| Analytical testing | Purity, identity, and batch verification | HPLC / LC-MS / mass spectrometry / COA | Supports documentation review |
| Storage and stability | Material form and handling considerations for peptide materials | Laboratory documentation / review literature | Supports research workflow planning |
Storage and stability are documentation topics, not use topics. Solid-state peptide literature describes degradation mechanisms such as deamidation, peptide-bond cleavage, and oxidation that can affect proteins and peptides [20]. Reviews of peptide physical stability also emphasize that intrinsic and external factors can affect aggregation behavior [21]. For RUO procurement, these sources support the need to record supplier storage guidance and maintain internal laboratory handling records.
| Research-Safe Statement | Why It Is Acceptable | Non-Compliant Version to Avoid |
| “BPC-157+TB-500 Blend is discussed here in relation to peptide identity, blend documentation, and cellular pathway research context.” | Describes literature context without making a product claim | “BPC-157+TB-500 Blend helps with a human outcome.” |
| “Researchers should review COA and identity data before procurement.” | Focuses on documentation and quality review | “Users should buy BPC-157+TB-500 Blend for results.” |
| “Pure Lab Peptides supplies BPC-157+TB-500 Blend as a research-use-only material.” | Clarifies intended use | “Pure Lab Peptides supplies BPC-157+TB-500 Blend for therapy.” |
| “The phrase buy BPC-157+TB-500 Blend online is addressed as research procurement intent.” | Qualifies commercial search intent | “Buy BPC-157+TB-500 Blend online for personal use.” |
| “Blend composition should be evaluated through documentation and identity review.” | Centers component-level verification | “The blend should be selected for combined effects.” |
Pure Lab Peptides presents BPC-157+TB-500 10mg Blend as a research-use-only material. The product is supplied as lyophilized powder with a stated purity claim of ≥99%, and a batch-specific COA is available for review. Researchers should review the Pure Lab Peptides BPC-157+TB-500 Blend research-use-only product details for RUO labeling, product details, purity information, and batch-specific documentation.
Supplier transparency matters because the documentation has to support internal research procurement records. Relevant review points include the product page, BPC-157+TB-500 Blend COA, lot-level traceability, storage and handling documentation, product form, labeled amount, identity information, and supplier language. The product page should be considered alongside the broader Pure Lab Peptides research peptide collection, research documentation articles, and shipping and returns information when procurement teams are documenting supplier evaluation.
Buy BPC-157+TB-500 Blend online should not be interpreted as personal-use guidance on this page. The phrase is addressed as laboratory procurement intent for qualified researchers reviewing RUO labeling, documentation, purity data, identity information, lot traceability, and supplier transparency.
Published literature may describe compound identity, peptide chemistry, analytical methods, or controlled research models. That literature does not convert an RUO material into a clinical, diagnostic, veterinary, or consumer product. Procurement teams should separate literature context from supplier-lot documentation.
A purity value is only one quality signal. Researchers should evaluate the purity percentage together with the analytical method, identity confirmation, lot number, product name, blend composition, and documentation source. This is especially important when reviewing a two-component research material.
A generic COA is weaker than a batch-specific COA because it may not connect the received material to a particular lot. For BPC-157+TB-500 Blend, researchers should match the lot number on the certificate to the product label and procurement record.
Supplier descriptions can help identify the product, but they cannot replace analytical documentation. A procurement file should preserve the product page, COA, lot number, purity method, identity information, and storage details needed for laboratory recordkeeping.
Researchers can buy BPC-157+TB-500 Blend online for laboratory research by reviewing an RUO supplier’s product page, batch-specific COA, purity documentation, identity information, storage guidance, and supplier transparency. Pure Lab Peptides provides a dedicated product page for BPC-157+TB-500 10mg Blend with RUO-focused product details.
Before buying BPC-157+TB-500 Blend online, researchers should check RUO labeling, component naming, batch-specific COA availability, lot number matching, analytical method, stated purity, product form, storage documentation, and supplier language. A compliant supplier should keep the page focused on research procurement rather than personal-use positioning.
A BPC-157+TB-500 Blend COA matters because it connects a specific lot to documented analytical information. Researchers should review the lot number, product name, test method, purity result, identity confirmation, and any chromatogram or mass data supplied with the batch-specific documentation.
BPC-157+TB-500 Blend is not intended for human or animal consumption. In this article, the compound is discussed only as a research-use-only laboratory material for qualified researchers and procurement teams evaluating documentation, supplier transparency, product labeling, purity data, and identity testing.
Research use only means BPC-157+TB-500 Blend is positioned for controlled laboratory research procurement and documentation review. It is not presented as a consumer product, clinical product, diagnostic product, veterinary product, or personal-use material. The procurement focus should remain on COA review, identity data, purity documentation, and lot traceability.
Published literature about BPC-157, TB-500, thymosin beta-4, and synthetic peptides should be interpreted as scientific context, not product-use guidance. Researchers should distinguish database records, analytical-method papers, structural studies, and model-specific literature from batch-specific documentation for the RUO material being procured.
For research teams comparing BPC-157+TB-500 Blend suppliers, prioritize COA availability, transparent RUO labeling, purity documentation, identity testing, storage information, and lot-level traceability. Review the BPC-157+TB-500 Blend product page for RUO labeling, purity information, and available batch-specific documentation before adding the material to procurement records.
Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.
Discount Applied Successfully!
Your savings have been added to the cart.
There are no reviews yet.